Active	Status	Sponsor type	Region	Phase	Filter
3 Active 1 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Tosti, Antonella
BRAVE-AA1, NCT03570749: A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata Efficacy and safety data from BRAVE-AA1 trial in adults with severe alopecia areata Apr 2021 - Apr 2021: Efficacy and safety data from BRAVE-AA1 trial in adults with severe alopecia areata From BRAVE-AA1 trial for alopecia areata Oct 2020 - Oct 2020: From BRAVE-AA1 trial for alopecia areata	Active, not recruiting	2/3	824	Japan, US, RoW	Baricitinib, LY3009104, Placebo	Eli Lilly and Company, Incyte Corporation	Alopecia Areata	02/21	01/25
NCT03066336: A Study to See if Low Level Laser Light Can Help to Treat Toenail Fungus	Withdrawn	N/A	54	US	Erchonia LunulaLaser	Erchonia Corporation	Onychomycosis of Toenail	11/21	11/21
Rosen, Ted
NCT03066336: A Study to See if Low Level Laser Light Can Help to Treat Toenail Fungus	Withdrawn	N/A	54	US	Erchonia LunulaLaser	Erchonia Corporation	Onychomycosis of Toenail	11/21	11/21
Hu, Shasa
No trials found